BDBM63292 MLS000375266::N-(2-methyl-1,3-benzothiazol-6-yl)-2-[4-(4-methylphenyl)-2-(3-pyridinyl)-5-thiazolyl]acetamide::N-(2-methyl-1,3-benzothiazol-6-yl)-2-[4-(4-methylphenyl)-2-pyridin-3-yl-1,3-thiazol-5-yl]acetamide::N-(2-methyl-1,3-benzothiazol-6-yl)-2-[4-(4-methylphenyl)-2-pyridin-3-yl-1,3-thiazol-5-yl]ethanamide::N-(2-methyl-1,3-benzothiazol-6-yl)-2-[4-(p-tolyl)-2-(3-pyridyl)thiazol-5-yl]acetamide::SMR000254519::cid_2444487

SMILES COc1ccc(Nc2nc(-c3cnc4c(c3)OC(C)(C)C(=O)N4)cn3ncnc23)cc1OC

InChI Key InChIKey=OTQOHEPYOOEQSQ-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 63292   

TargetTyrosine-protein kinase SYK(Human)
Nanjing Ruijie Pharma Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 63292BDBM63292(7-(8-((3,4-dimethoxyphenyl)amino)-[1,2,4]triazolo[...)
Affinity DataIC50: 275nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/27/2026
Entry Details
US Patent